Related Experiment Videos
Septal myectomy for obstructive hypertrophic cardiomyopathy
Joseph A Dearani1, Gordon K Danielson
1Mayo Clinic, Division of Cardiovascular Surgery, Rochester, MN 55905, USA.
Summary
Septal myectomy is an effective surgical treatment for obstructive hypertrophic cardiomyopathy (HCM), significantly improving cardiac symptoms and reducing left ventricular outflow tract obstruction (LVOTO) in patients of all ages.
Area of Science:
- Cardiology
- Cardiac Surgery
Background:
- Obstructive hypertrophic cardiomyopathy (HCM) causes significant symptoms and left ventricular outflow tract obstruction (LVOTO).
- Septal myectomy is a surgical option for managing obstructive HCM.
Purpose of the Study:
- To evaluate the efficacy and safety of septal myectomy in relieving LVOTO and improving symptoms in patients with obstructive HCM.
- To compare long-term outcomes of septal myectomy with the natural history of nonoperated patients.
Main Methods:
- Review of outcomes for adult and pediatric patients undergoing septal myectomy.
- Assessment of echocardiographic LVOT gradients and symptomatic improvement.
- Analysis of early and late mortality and long-term survivorship.
Main Results:
- Septal myectomy effectively reduces LVOT gradients (median 0-5 mm Hg at follow-up) and improves cardiac symptoms in the majority of patients (90% improve by at least one functional class).
- The procedure has low early mortality (0%-2.5%) and favorable long-term survivorship compared to nonoperated patients.
- Simultaneous repair of associated cardiac lesions is feasible during myectomy.
Conclusions:
- Septal myectomy is a safe and effective treatment for obstructive HCM, offering significant symptomatic relief and improved survival.
- The procedure provides a valuable benchmark for evaluating emerging nonsurgical alternatives for obstructive HCM.